Combination therapies employing a composition comprising a HMG CoA reductase inhibitor and a vitamin B6 related compound

Details for Australian Patent Application No. 2004305154 (hide)

Owner Medicure International Inc.

Inventors Khalil, Ahmad; Zettler, Marjorie; Friesen, Albert

Agent Davies Collison Cave

Pub. Number AU-A-2004305154

PCT Pub. Number WO2005/060975

Priority 60/531,605 23.12.03 US; 60/586,215 09.07.04 US

Filing date 23 December 2004

Wipo publication date 7 July 2005

International Classifications

A61K 31/366 (2006.01) - having six-membered rings, e.g. delta-lactones

A61K 31/4355 (2006.01)

A61K 31/4412 (2006.01) - having oxo groups directly attached to the heterocyclic ring

A61K 31/4415 (2006.01) - Pyridoxine, i.e.vitamin B

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

13 July 2006 PCT application entered the National Phase

  PCT publication WO2005/060975 Priority application(s): WO2005/060975

21 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004305163-Rail-guided transport system

2004305150-Modular prefabricated spa